BALTIMORE--(BUSINESS WIRE)--Profectus BioSciences, Inc. (Profectus), a clinical stage biopharmaceutical company focused on the development of novel vaccine candidates for chronic viral infections, announced today that the company will present at three upcoming conferences, as well as the online industry forum BioConference Live. These conferences will take Profectus BioSciences across the country and provide several unique opportunities for one-on-one meetings as the company continues to grow its business and its pipeline.
